missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Tn Antigen Monoclonal Antibody (Tn 218)

Descripción
MA1-90544 stains Tn antigen in epithelial carcinoma, pancreatic, colon, stomach and breast. A suggested positive control for this product is human gastrointestinal tumor. The antibody is supplied as concentrated tissue culture supernatant in PBS with 0.05% azide.
Aberrant glycosylation is a hallmark of cancer cells. The blood group precursors T (Thomsen-Friedenreich) and Tn epitopes are shielded in healthy and benign-diseased tissues but uncovered in approximately 90% of carcinomas. T and Tn glycoproteins are specific, autoimmunogenic pancarcinoma antigens. These antigens may also be found in neoplastic blood cells. Fundamental, chemical and physical aspects of these glycoproteins of primary carcinomas are discussed first. Tn and T epitopes are cell and tissue adhesion molecules, essential in invasion by and metastasis of carcinoma which includes adherent and proliferative phases. Immunohistochemical studies of the extent of Tn antigen expression in primamry breast carcinoma demonstrate its highly significant correlation with clinical pathological tumor stages, and hence its value as a reliable prognisticator.
Especificaciones
Especificaciones
| Antígeno | Tn Antigen |
| Aplicaciones | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Clasificación | Monoclonal |
| Clon | Tn 218 |
| Concentración | 0.20 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 0.05% sodium azide; pH 7.2 |
| Alias de gen | Thomsen-Friedenreich antigen |
| Especie del huésped | Mouse |
| Inmunógeno | Asialo ovine submaxillary mucin (AOSM). |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?